Platinum Group Metals against Parasites: State of the Art and Future Perspectives

References

1. ChristakiE. Classification of Parasitic Diseases. The Surgical Management of Parasitic DiseasesTsoulfas, G.; Hoballah, J.J.; Velmahos, G.C.; Ho, Y-H., Eds.; Springer International Publishing: Cham,2020234510.1007/978‑3‑030‑47948‑0_2
   [Google Scholar]
2. NunesM.C.P. Guimarães JúniorM.H. DiamantinoA.C. GelapeC.L. FerrariT.C.A. Cardiac manifestations of para-sitic diseases.Heart2017103965165810.1136/heartjnl‑2016‑30987028285268
   [Google Scholar]
3. HalliezM.C.M. BuretA.G. Gastrointestinal parasites and the neural control of gut functions.Front. Cell. Neurosci.2015945210.3389/fncel.2015.0045226635531
   [Google Scholar]
4. Silva PereiraS. TrindadeS. De NizM. FigueiredoL.M. Tissue tropism in parasitic diseases.Open Biol.20199519003610.1098/rsob.19003631088251
   [Google Scholar]
5. NorganA.P. PrittB.S. Parasitic infections of the skin and subcutaneous tissues.Adv. Anat. Pathol.201825210612310.1097/PAP.000000000000018329351090
   [Google Scholar]
6. FikaduM. AshenafiE. Malaria: An overview.Infect. Drug Resist.2023163339334710.2147/IDR.S40566837274361
   [Google Scholar]
7. MolyneuxD.H. HotezP.J. FenwickA. “Rapid-impact interventions”: How a policy of integrated control for Africa’s neglected tropical diseases could benefit the poor.PLoS Med.2005211e33610.1371/journal.pmed.002033616212468
   [Google Scholar]
8. WHONeglected tropical diseases.2024Available From https://www.who.int/news-room/questions-and-answers/item/neglected-tropical-diseases
   [Google Scholar]
9. Ruang-areerateT. SukphattanaudomchokeC. ThitaT. LeelayoovaS. PiyarajP. MungthinM. SuwanninP. PolpanichD. TangchaikeereeT. JangpatarapongsaK. ChoowongkomonK. SiripattanapipongS. Development of loop-mediated isothermal amplification (LAMP) assay using SYBR safe and gold-nanoparticle probe for detection of Leishmania in HIV patients.Sci. Rep.20211111215210.1038/s41598‑021‑91540‑534108543
   [Google Scholar]
10. WeinbergE.D. Roles of metallic ions in host-parasite interactions.Bacteriol. Rev.196630113615110.1128/br.30.1.136‑151.19665324644
    [Google Scholar]
11. TurnerR.J. The good, the bad, and the ugly of metals as antimicrobials.Biometals202337354555910.1007/s10534‑023‑00565‑y38112899
    [Google Scholar]
12. SierraE.J.T. CordeiroC.F. de Figueiredo DinizL. CaldasI.S. HawkesJ.A. CarvalhoD.T. Coumarins as potential antiprotozoal agents: Biological activities and mechanism of ac-tion.Rev. Bras. Farmacogn.202131559261110.1007/s43450‑021‑00169‑y
    [Google Scholar]
13. KucharskiD.J. JaszczakM.K. BoratyńskiP.J. A review of modifications of quinoline antimalarials: Mefloquine and (hydroxy)Chloroquine.Molecules2022273100310.3390/molecules2703100335164267
    [Google Scholar]
14. MbabaM. GoldingT.M. SmithG.S. Recent advances in the biological investigation of organometallic platinum-group metal (Ir, Ru, Rh, Os, Pd, Pt) complexes as antimalarial agents.Molecules20202522527610.3390/molecules2522527633198217
    [Google Scholar]
15. ZhangC. XuC. GaoX. YaoQ. Platinum-based drugs for cancer therapy and anti-tumor strategies.Theranostics20221252115213210.7150/thno.6942435265202
    [Google Scholar]
16. BonnetS. Ruthenium-based photoactivated chemotherapy.J. Am. Chem. Soc.202314543233972341510.1021/jacs.3c0113537846939
    [Google Scholar]
17. BajwaH.U.R. KhanM.K. AbbasZ. RiazR. RehmanT. AbbasR.Z. AleemM.T. AbbasA. AlmutairiM.M. Al-shammariF.A. AlraeyY. AlouffiA. Nanoparticles: Synthesis and their role as potential drug candidates for the treatment of parasitic diseases.Life (Basel)202212575010.3390/life1205075035629416
    [Google Scholar]
18. StringerT. QuinteroM.A.S. WiesnerL. SmithG.S. NordlanderE. Evaluation of PTA-derived ruthenium(II) and iridium(III) quinoline complexes against chloroquine-sensitive and resistant strains of the Plasmodium falciparum malaria parasite.J. Inorg. Biochem.201919116417310.1016/j.jinorgbio.2018.11.01830529881
    [Google Scholar]
19. KumariG. GuptaA. SahR.K. GautamA. SainiM. GuptaA. KushawahaA.K. SinghS. SasmalP.K. Development of mitochondria targeting AIE‐active cyclometalated iridium complexes as potent antimalarial agents.Adv. Healthc. Mater.2023129220241110.1002/adhm.20220241136515128
    [Google Scholar]
20. ChellanP. LandK.M. ShokarA. AuA. AnS.H. TaylorD. SmithP.J. ChibaleK. SmithG.S. Di- and trinuclear ruthenium-, rhodium-, and iridium-functionalized pyridyl aromatic ethers: A new class of antiparasitic agents.Organometallics201332174793480410.1021/om400493k
    [Google Scholar]
21. LoiseauP.M. MbongoN. BoriesC. BoulardY. CraciunescuD.G. In vivo antileishmanial action of Ir-(COD)-pentamidine tetraphenylborate on Leishmania donovani and Leishmania major mouse models.Parasite20007210310810.1051/parasite/200007210310887656
    [Google Scholar]
22. MbongoN. LoiseauP.M. CraciunescuD.G. Robert-GeroM. Synergistic effect of Ir-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani.Acta Trop.199870223924510.1016/S0001‑706X(98)00018‑79698271
    [Google Scholar]
23. DavisK.M. BittingA.L. MarkwalterC.F. BauerW.S. WrightD.W. Iridium(III) luminescent probe for detection of the malarial protein biomarker histidine rich protein-II. J. Vis. Exp.2015e52856101e5285610.3791/5285626273845
    [Google Scholar]
24. DavisK.M. BittingA.L. WrightD.W. On-particle detection of Plasmodium falciparum histidine-rich protein II by a “switch-on” iridium(III) probe.Anal. Biochem.2014445606610.1016/j.ab.2013.10.00724129120
    [Google Scholar]
25. QuinsonJ. Iridium and IrOx nanoparticles: An overview and review of syntheses and applications.Adv. Colloid Interface Sci.202230310264310.1016/j.cis.2022.10264335334351
    [Google Scholar]
26. ZhenW. LiuY. LinL. BaiJ. JiaX. TianH. JiangX. BSA‐IrO 2: Catalase‐like nanoparticles with high photothermal conversion efficiency and a high x‐ray absorption coefficient for anti‐inflammation and antitumor theranostics.Angew. Chem. Int. Ed.20185732103091031310.1002/anie.20180446629888846
    [Google Scholar]
27. ShinJ. ChoiS.J. YounD.Y. KimI.D. Exhaled VOCs sensing properties of WO3 nanofibers functionalized by Pt and IrO2 nanoparticles for diagnosis of diabetes and halitosis.J. Electroceram.201229210611610.1007/s10832‑012‑9755‑y
    [Google Scholar]
28. KangX. LiuJ. TianH. YangB. NuLi, Y.; Yang, C. Sputtered iridium oxide modified flexible parylene microelectrodes array for electrical recording and stimulation of muscles.Sens. Actuators B Chem.201622526727810.1016/j.snb.2015.11.050
    [Google Scholar]
29. BrittenN.S. ButlerJ.A. Ruthenium metallotherapeutics: Novel approaches to combatting parasitic infections.Curr. Med. Chem.202229315159517810.2174/092986732966622040110544435366762
    [Google Scholar]
30. StuderV. AnghelN. DesiatkinaO. FelderT. BoubakerG. AmdouniY. RamseierJ. HungerbühlerM. KempfC. HeverhagenJ.T. HemphillA. RuprechtN. FurrerJ. PăunescuE. Conjugates containing two and three trithiolato-bridged Dinuclear Ruthenium(II)-arene units as in vitro antiparasitic and anticancer agents.Pharmaceuticals (Basel)2020131247110.3390/ph1312047133339451
    [Google Scholar]
31. Al NasrI.S. KokoW.S. KhanT.A. GürbüzN. ÖzdemirI. HamdiN. Evaluation of ruthenium(II) N-heterocyclic carbene complexes as enzymatic inhibitory agents with antioxidant, antimicrobial, antiparasitical and antiproliferative activity.Molecules2023283135910.3390/molecules2803135936771026
    [Google Scholar]
32. SouzaN.B. AguiarA.C.C. OliveiraA.C. TopS. PigeonP. JaouenG. GoulartM.O.F. KrettliA.U. Antiplasmodial activity of iron(II) and ruthenium(II) organometallic complexes against Plasmodium falciparum blood parasites.Mem. Inst. Oswaldo Cruz2015110898198810.1590/0074‑0276015016326602875
    [Google Scholar]
33. AnchuriS.S. ThotaS. BongoniR.N. YerraR. ReddyR.N. DhulipalaS. Antimicrobial and antimalarial activity of novel synthetic Mononuclear Ruthenium(II) Compounds.J. Chin. Chem. Soc. (Taipei)201360215315910.1002/jccs.201200301
    [Google Scholar]
34. Colina-VegasL. da CruzB. Silva, M.; de Souza Pereira, C.; Isis Barros, A.; Araújo Nobrega, J.; Navarro, M.; Rottmann, M.; D’Alessandro, S.; Basilico, N.; Azevedo Batista, A.; Moreira, D.R.M. Antimalarial agents derived from metal-amodiaquine complexes with activity in multiple stages of the plasmodium life cycle.Chemistry20232955e20230164210.1002/chem.20230164237427863
    [Google Scholar]
35. CostaM.S. GonçalvesY.G. NunesD.C.O. NapolitanoD.R. MaiaP.I.S. RodriguesR.S. RodriguesV.M. Von PoelhsitzG. YoneyamaK.A.G. Anti-Leishmania activity of new ruthenium(II) complexes: Effect on parasite-host interaction.J. Inorg. Biochem.201717522523110.1016/j.jinorgbio.2017.07.02328783554
    [Google Scholar]
36. FandzlochM. ArriagaJ.M.M. Sánchez-MorenoM. WojtczakA. JezierskaJ. SitkowskiJ. WiśniewskaJ. SalasJ.M. ŁakomskaI. Strategies for overcoming tropical disease by ruthenium complexes with purine analog: Application against Leishmania spp. and Trypanosoma cruzi.J. Inorg. Biochem.201717614415510.1016/j.jinorgbio.2017.08.01828910663
    [Google Scholar]
37. RivasF. Del MármolC. ScaleseG. Pérez-DíazL. MachadoI. BlacqueO. MedeirosA. CominiM. GambinoD. New multifunctional Ru(II) organometallic compounds show activity against Trypanosoma brucei and Leishmania infantum.J. Inorg. Biochem.202223711201610.1016/j.jinorgbio.2022.11201636244312
    [Google Scholar]
38. LakshmiB.A. ReddyA.S. SangubotlaR. HongJ.W. KimS. Ruthenium(II)-curcumin liposome nanoparticles: Synthesis, characterization, and their effects against cervical cancer.Colloids Surf. B Biointerfaces202120411177310.1016/j.colsurfb.2021.11177333933878
    [Google Scholar]
39. Martínez-CarmonaM. HoQ.P. MorandJ. GarcíaA. OrtegaE. ErthalL.C.S. Ruiz-HernandezE. SantanaM.D. RuizJ. Vallet-RegíM. Gun’koY.K. Amino-functionalized mesoporous silica nanoparticle-encapsulated octahedral organoruthenium complex as an efficient platform for combatting cancer.Inorg. Chem.20205914102751028410.1021/acs.inorgchem.0c0143632628466
    [Google Scholar]
40. LuY. ZhuD. LeQ. WangY. WangW. Ruthenium-based antitumor drugs and delivery systems from monother-apy to combination therapy.Nanoscale20221444163391637510.1039/D2NR02994D36341705
    [Google Scholar]
41. SolimanN. SolV. OukT.S. ThomasC.M. GasserG. Encapsulation of a Ru(II) polypyridyl complex into polylactide nanoparticles for antimicrobial photodynamic therapy.Pharmaceutics2020121096110.3390/pharmaceutics1210096133066200
    [Google Scholar]
42. YinC. WangZ. DingX. ChenX. WangJ. YangE. WangW. MartinL.L. SunD. Crystalline ruthenium polypyridine nanoparticles: A targeted treatment of bacterial infection with multifunctional antibacterial, adhesion and surface-anchoring photosensitizer properties.J. Mater. Chem. B Mater. Biol. Med.20219183808382510.1039/D1TB00103E33979422
    [Google Scholar]
43. MikheenkoI.P. Gomez-BolivarJ. MerrounM. SharmaS. MacaskieL.E. High Resolution electron microscopy study of biologically derived ruthenium and palladium/ruthenium nanoparticles.Proceedings of the 2016 International Conference on Nanomaterials: Application & Properties (NAP)14-19 September 2016Lviv, Ukraine201610.1109/NAP.2016.7757229
    [Google Scholar]
44. Soldevila-BarredaJ.J. HabtemariamA. Romero-CanelónI. SadlerP.J. Half-sandwich rhodium(III) transfer hydrogenation catalysts: Reduction of NAD+ and pyruvate, and antipro-liferative activity.J. Inorg. Biochem.201515332233310.1016/j.jinorgbio.2015.10.00826601938
    [Google Scholar]
45. ZhuW. GunnoeT.B. Advances in rhodium-catalyzed oxidative arene alkenylation.Acc. Chem. Res.202053492093610.1021/acs.accounts.0c0003632239913
    [Google Scholar]
46. LiuC.X. YinS.Y. ZhaoF. YangH. FengZ. GuQ. YouS.L. Rhodium-Catalyzed Asymmetric C–H Functionalization Reactions.Chem. Rev.202312316100791013410.1021/acs.chemrev.3c0014937527349
    [Google Scholar]
47. KatsarosN. AnagnostopoulouA. Rhodium and its compounds as potential agents in cancer treatment.Crit. Rev. Oncol. Hematol.200242329730810.1016/S1040‑8428(01)00222‑012050021
    [Google Scholar]
48. SohrabiM. SaeediM. LarijaniB. MahdaviM. Recent advances in biological activities of rhodium complexes: Their applications in drug discovery research.Eur. J. Med. Chem.202121611330810.1016/j.ejmech.2021.11330833713976
    [Google Scholar]
49. KnollJ.D. TurroC. Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy.Coord. Chem. Rev.2015282-28311012610.1016/j.ccr.2014.05.01825729089
    [Google Scholar]
50. MálikováK. MasarykL. ŠtarhaP. Anticancer half-sandwich rhodium(III) Complexes.Inorganics (Basel)2021942610.3390/inorganics9040026
    [Google Scholar]
51. CuiP.F. LiuX.R. JinG.X. Supramolecular architectures bearing half-sandwich iridium- or rhodium-based carboranes: Design, synthesis, and applications.J. Am. Chem. Soc.202314536194401945710.1021/jacs.3c0556337643971
    [Google Scholar]
52. GeldmacherY. SplithK. KitanovicI. AlborziniaH. CanS. RubbianiR. NazifM.A. WefelmeierP. ProkopA. OttI. WölflS. NeundorfI. SheldrickW.S. Cellular impact and selectivity of half-sandwich organorhodium(III) anticancer complexes and their organoiridium(III) and trichloridorhodium(III) counterparts.J. Biol. Inorg. Chem.201217463164610.1007/s00775‑012‑0883‑222358334
    [Google Scholar]
53. SharmaV. Therapeutic drugs for targeting chloroquine resistance in malaria.Mini Rev. Med. Chem.20055433735110.2174/138955705354402915853624
    [Google Scholar]
54. StringerT. TaylorD. GuzgayH. ShokarA. AuA. SmithP.J. HendricksD.T. LandK.M. EganT.J. SmithG.S. Polyamine quinoline rhodium complexes: Synthesis and pharmacological evaluation as antiparasitic agents against Plasmodium falciparum and Trichomonas vaginalis.Dalton Trans.20154433149061491710.1039/C5DT02378E26226082
    [Google Scholar]
55. Rodriguez-CabezasM.N. Mesa-ValleC.M. AzzouzS. Moraleda-LindezV. CraciunescuD. Gutierrez-RiosM.T. De FrutosM.I. OsunaA. In vitro and in vivo activity of New Rhodium (III) Complexes against Leishmania donovani.Pharmacology200163211211910.1159/00005612111490204
    [Google Scholar]
56. BaartzesN. JordaanA. WarnerD.F. CombrinckJ. TaylorD. ChibaleK. SmithG.S. Antimicrobial evaluation of neutral and cationic iridium(III) and rhodium(III) aminoquin-oline-benzimidazole hybrid complexes.Eur. J. Med. Chem.202020611269410.1016/j.ejmech.2020.11269432861176
    [Google Scholar]
57. JordaanL. NdlovuM.T. MkhizeS. NgubaneS. LootsL. DuffyS. AveryV.M. ChellanP. Investigating the antiplasmodial activity of substituted cyclopentadienyl rhodium and iridium complexes of 2-(2-pyridyl)benzimidazole.J. Organomet. Chem.202296212227310.1016/j.jorganchem.2022.122273
    [Google Scholar]
58. XuL. LiuD. ChenD. LiuH. YangJ. Size and shape controlled synthesis of rhodium nanoparticles.Heliyon201951e0116510.1016/j.heliyon.2019.e0116530723833
    [Google Scholar]
59. KangS. ShinW. ChoiM.H. AhnM. KimY.K. KimS. MinD.H. JangH. Morphology-controlled synthesis of rhodium nanoparticles for cancer phototherapy.ACS Nano20181276997700810.1021/acsnano.8b0269829901981
    [Google Scholar]
60. NabiyevaT. MarschnerC. BlomB. Synthesis, structure and anti-cancer activity of osmium complexes bearing π-bound arene substituents and phosphane Co-Ligands: A review.Eur. J. Med. Chem.202020111248310.1016/j.ejmech.2020.11248332592914
    [Google Scholar]
61. ManiA. FengT. GandiosoA. VinckR. NotaroA. GourdonL. BurckelP. SaubaméaB. BlacqueO. CariouK. BelgaiedJ.E. ChaoH. GasserG. Structurally simple osmium(II) polypyridyl complexes as photosensitizers for photodynamic therapy in the near infrared**.Angew. Chem. Int. Ed.20236220e20221834710.1002/anie.20221834736917074
    [Google Scholar]
62. CastillaJ.J. Mesa-ValleC.M. Sanchez-MorenoM. ArnedoT. RosalesM.J. MascaroC. CraciunescuD. OsunaA. In vitro activity and biochemical effectiveness of new organometallic complexes of osmium(III) against Leishmania donovani and Trypanosoma cruzi.Arzneimittelforschung199646109909968931894
    [Google Scholar]
63. GavrilutaA. BüchelG.E. FreitagL. NovitchiG. Tom-masinoJ.B. JeanneauE. KuhnP.S. GonzálezL. ArionV.B. LuneauD. Mechanism elucidation of the cis-trans isomerization of an azole ruthenium-nitrosyl complex and its osmium counterpart.Inorg. Chem.201352116260627210.1021/ic400482423675748
    [Google Scholar]
64. TrindadeJ.D.A.S. Freire-de-LimaC.G. Côrte-RealS. Decote-RicardoD. Freire de LimaM.E. Drug repurposing for Chagas disease: In vitro assessment of nimesulide against Trypanosoma cruzi and insights on its mechanisms of action.PLoS One20211610e025829210.1371/journal.pone.025829234679091
    [Google Scholar]
65. CarneiroF.M. da CruzA.B. MaiaM.M. TaniwakiN.N. PereiraI.S. NamiyamaG.M. GavaR. HiramotoR.M. Vi-centeB. MidlejV. MarianteR.M. Pereira-ChioccolaV.L. Extracellular vesicles from Leishmania (Leishmania) infantum contribute in stimulating immune response and immunosuppression in hosts with visceral leishmaniasis.Microorganisms202412227010.3390/microorganisms1202027038399674
    [Google Scholar]
66. HairM. YanaseR. Moreira-LeiteF. WheelerR.J. SádlováJ. VolfP. VaughanS. SunterJ.D. Whole cell reconstructions of Leishmania mexicana through the cell cycle.PLoS Pathog.2024202e101205410.1371/journal.ppat.101205438416776
    [Google Scholar]
67. RiceK.M. GinjupalliG.K. ManneN.D.P.K. JonesC.B. BloughE.R. A review of the antimicrobial potential of precious metal derived nanoparticle constructs.Nanotechnology2019303737200110.1088/1361‑6528/ab0d3830840941
    [Google Scholar]
68. RosenbergB. Van CampL. KrigasT. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode.Nature1965205497269869910.1038/205698a014287410
    [Google Scholar]
69. RosenbergB. VanCampL. The successful regression of large solid sarcoma 180 tumors by platinum compounds.Cancer Res.1970306179918025457941
    [Google Scholar]
70. DasariS. Bernard TchounwouP. Cisplatin in cancer therapy: Molecular mechanisms of action.Eur. J. Pharmacol.201474036437810.1016/j.ejphar.2014.07.02525058905
    [Google Scholar]
71. RomaniA.M.P. Cisplatin in cancer treatment.Biochem. Pharmacol.202220611532310.1016/j.bcp.2022.11532336368406
    [Google Scholar]
72. HavasiA. CainapS.S. HavasiA.T. CainapC. Ovarian cancer—insights into platinum resistance and overcoming it.Medicina (Kaunas)202359354410.3390/medicina5903054436984544
    [Google Scholar]
73. RichardsonD.L. EskanderR.N. O’MalleyD.M. Advances in ovarian cancer care and unmet treatment needs for patients with platinum resistance.JAMA Oncol.20239685185910.1001/jamaoncol.2023.019737079311
    [Google Scholar]
74. Mesa-ValleC.M. CraciunescuD. Parrondo-IglesiasE. OsunaA. In vitro action of platinum (II) and platinum (IV) complexes on Trypanosoma cruzi and Leishmania donovani.Arzneimittelforschung19893988388422684173
    [Google Scholar]
75. NavarroM. GabbianiC. MessoriL. GambinoD. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: Recent achievements and perspectives.Drug Discov. Today20101523-241070107810.1016/j.drudis.2010.10.00520974285
    [Google Scholar]
76. Sánchez-DelgadoR.A. AnzellottiA. Metal complexes as chemotherapeutic agents against tropical diseases: Trypanosomiasis, malaria and leishmaniasis.Mini Rev. Med. Chem.200441233010.2174/138955704348749314754440
    [Google Scholar]
77. VieitesM. OteroL. SantosD. TolozaJ. FigueroaR. NorambuenaE. Olea-AzarC. AguirreG. CerecettoH. GonzálezM. MorelloA. MayaJ.D. GaratB. GambinoD. Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents.J. Inorg. Biochem.20081025-61033104310.1016/j.jinorgbio.2007.12.00518226837
    [Google Scholar]
78. O’SullivanM. The battle against trypanosomiasis and leishmaniasis: Metal-based and natural product inhibitors of trypanothione reductase.Curr. Med. Anti Infect. Agents20054435537810.2174/156801205774322241
    [Google Scholar]
79. VisbalG. MarchánE. MaldonadoA. SimoniZ. NavarroM. Synthesis and characterization of platinum–sterol hydrazone complexes with biological activity against Leishmania (L.) mexicana.J. Inorg. Biochem.2008102354755410.1016/j.jinorgbio.2007.11.00218164763
    [Google Scholar]
80. YadavM.K. RajputG. SrivastavaK. SinghR.K. MishraR. DrewM.G.B. SinghN. Anti-leishmanial activity of Ni(II), Pd(II) and Pt(II) β-oxodithioester complexes.New J. Chem.20153986358636610.1039/C5NJ00765H
    [Google Scholar]
81. TabriziL. ChiniforoshanH. New platinum(II) complexes of CCC-pincer N-heterocyclic carbene ligand: Synthesis, characterization, cytotoxicity and antileishmanial activity.J. Organomet. Chem.20168189810510.1016/j.jorganchem.2016.06.013
    [Google Scholar]
82. PatraS.C. Saha RoyA. BanerjeeS. BanerjeeA. Das SahaK. BhadraR. PramanikK. GhoshP. Palladium(II) and platinum(II) complexes of glyoxalbis(N-aryl)osazone: Molecular and electronic structures, anti-microbial activities and DNA-binding study.New J. Chem.201943259891990110.1039/C9NJ00223E
    [Google Scholar]
83. LapasamA. KolliparaM.R. A survey of crystal structures and biological activities of platinum group metal complexes containing N -acylthiourea ligands.Phosphorus Sulfur Silicon Relat. Elem.20201951077980410.1080/10426507.2020.1764956
    [Google Scholar]
84. SilvaG.L. DiasJ.S.M. SilvaH.V.R. TeixeiraJ.D.S. De SouzaI.R.B. GuimarãesE.T. de Magalhães MoreiraD.R. SoaresM.B.P. BarbosaM.I.F. DoriguettoA.C. Synthesis, crystal structure and leishmanicidal activity of new trimethoprim Ru(III), Cu(II) and Pt(II) metal complexes.J. Inorg. Biochem.202020511100210.1016/j.jinorgbio.2020.11100232007697
    [Google Scholar]
85. ZhangJ.J. XuQ.J. ZhangY. ZhouQ. LvR. ChenZ. HeW. Recent advances in nanocarriers for clinical platinum(II) anticancer drugs.Coord. Chem. Rev.202450521567610.1016/j.ccr.2024.215676
    [Google Scholar]
86. ChenJ. ZhangZ. MaJ. Nezamzadeh-EjhiehA. LuC. PanY. LiuJ. BaiZ. Current status and prospects of MOFs in controlled delivery of Pt anticancer drugs.Dalton Trans.202352196226623810.1039/D3DT00413A37070759
    [Google Scholar]
87. MalodeU. PatilY.S. SelokarY.N. YadavP.R. BhagatR.P. NikoseV.M. ThakareR.U. NimbarteS. Sustainable approaches for the synthesis of biogenic platinum nanoparticles.Bull. Natl. Res. Cent.202347113010.1186/s42269‑023‑01104‑y
    [Google Scholar]
88. BlochK. PardesiK. SatrianoC. GhoshS. Bacteriogenic platinum nanoparticles for application in nanomedicine.Front Chem.2021962434410.3389/fchem.2021.62434433763405
    [Google Scholar]
89. CzarnomysyR. RadomskaD. SzewczykO.K. RoszczenkoP. BielawskiK. Platinum and palladium complexes as promising sources for antitumor treatments.Int. J. Mol. Sci.20212215827110.3390/ijms2215827134361037
    [Google Scholar]
90. SavićA. MarzoT. ScalettiF. MassaiL. BartoliG. HoogenboomR. MessoriL. Van DeunR. Van HeckeK. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: Synthesis and characterization, cytotoxicity and reactivity towards biomolecules.Biometals2019321334710.1007/s10534‑018‑0155‑x30367340
    [Google Scholar]
91. KazimirA. SchwarzeB. LönneckeP. JelačaS. MijatovićS. Maksimović-IvanićD. Hey-HawkinsE. Metallodrugs against breast cancer: Combining the tamoxifen vector with platinum(II) and palladium(II) complexes.Pharmaceutics202315268210.3390/pharmaceutics1502068236840003
    [Google Scholar]
92. CairesA.C.F. Recent advances involving palladium (II) complexes for the cancer therapy.Anticancer. Agents Med. Chem.20077548449110.2174/18715200778166866117896909
    [Google Scholar]
93. ArugueteD. MillerK. WallaceA. BlakneyT. MuccioD. PellR. WilliamsonC. The effects of palladium coordination complex speciation and concentration upon the ubiquitous bacterial species Pseudomonas aeruginosa.Ecotoxicol. Environ. Saf.202325111451210.1016/j.ecoenv.2023.11451236634480
    [Google Scholar]
94. PlutínA.M. AlvarezA. MoceloR. RamosR. CastellanoE.E. da SilvaM.M. VillarrealW. PavanF.R. MeiraC.S. FilhoJ.S.R. MoreiraD.R.M. SoaresM.B.P. BatistaA.A. Palladium(II)/N,N-disubstituted-N′-acylthioureas complexes as anti-Mycobacterium tuberculosis and anti- Trypanosoma cruzi agents.Polyhedron2017132707710.1016/j.poly.2017.05.003
    [Google Scholar]
95. Al-JanabiA.S.M. AlheetyM.A. Al-SamraiO.A.Y. ShaabanS. KibarB. CacanE. Anti-cancer and anti-fungal evaluation of novel palladium(II) 1-phenyl-1H-tetrazol-5-thiol complexes.Inorg. Chem. Commun.202012110819310.1016/j.inoche.2020.108193
    [Google Scholar]
96. GenovaP. VaradinovaT. MatesanzA.I. MarinovaD. SouzaP. Toxic effects of bis(thiosemicarbazone) compounds and its palladium(II) complexes on herpes simplex virus growth.Toxicol. Appl. Pharmacol.2004197210711210.1016/j.taap.2004.02.00615163546
    [Google Scholar]
97. ChellanP. Shunmoogam-GoundenN. HendricksD.T. GutJ. RosenthalP.J. LateganC. SmithP.J. ChibaleK. SmithG.S. Synthesis, structure and in vitro biological screening of palladium(II) complexes of functionalised salicylaldimine thiosemicarbazones as antimalarial and anticancer agents.Eur. J. Inorg. Chem.20102010223520352810.1002/ejic.201000317
    [Google Scholar]
98. RostánS. PortoS. BarbosaC.L.N. AssisD. AlvarezN. MachadoF.S. MahlerG. OteroL. A novel palladium complex with a coumarin-thiosemicarbazone hybrid ligand inhibits Trypanosoma cruzi release from host cells and lowers the parasitemia in vivo.Eur. J. Biochem.202328871172310.1007/s00775‑023‑02020‑237768364
    [Google Scholar]
99. VelásquezA.M.A. RibeiroW.C. VennV. CastelliS. CamargoM.S. de AssisR.P. de SouzaR.A. RibeiroA.R. PassalacquaT.G. da RosaJ.A. BavieraA.M. MauroA.E. DesideriA. Almeida-AmaralE.E. GraminhaM.A.S. Efficacy of a binuclear cyclopalladated compound therapy for cutaneous leishmaniasis in the murine model of infection with leishmania amazonensis and its inhibitory effect on topoisomerase 1B.Antimicrob. Agents Chemother.2017618e00688e1710.1128/AAC.00688‑1728507113
    [Google Scholar]
100. FrancoL.P. de GóisE.P. CodonhoB.S. PavanA.L.R. de Oliveira PereiraI. MarquesM.J. de AlmeidaE.T. Palladium(II) imine ligands cyclometallated complexes with a potential leishmanicidal activity on Leishmania (L.) amazonensis.Med. Chem. Res.20132231049105610.1007/s00044‑012‑0095‑x
     [Google Scholar]
101. PaladiC.S. PimentelI.A.S. KatzS. CunhaR.L.O.R. JudiceW.A.S. CairesA.C.F. BarbiériC.L. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.PLoS Negl. Trop. Dis.201265e162610.1371/journal.pntd.000162622616018
     [Google Scholar]
102. NavarroM. BetancourtA. HernándezC. MarchánE. Palladium polypyridyl complexes: Synthesis, characterization, DNA interaction and biological activity on Leishmania (L.) mexicana.J. Braz. Chem. Soc.20081971355136010.1590/S0103‑50532008000700018
     [Google Scholar]
103. CunhaL.C. LageD.P. FerreiraL.S. Saboia-VahiaL. CoelhoE.A.F. BeloV.S. Teixeira-NetoR.G. SoaresL.F. ChagasR.C.R. da SilvaE.S. Leishmanicidal activity of ibuprofen and its complexes with Ni(II), Mn(II) and Pd(II).Inorg. Chem. Commun.202011310775610.1016/j.inoche.2019.107756
     [Google Scholar]
104. JoudehN. SaragliadisA. KosterG. MikheenkoP. LinkeD. Synthesis methods and applications of palladium nanoparticles: A review.Front. Nanotechnol.202241062608
     [Google Scholar]
105. TrzeciakA.M. AugustyniakA.W. The role of palladium nanoparticles in catalytic C–C cross-coupling reactions.Coord. Chem. Rev.201938412010.1016/j.ccr.2019.01.008
     [Google Scholar]
106. NarayananK.B. SakthivelN. Biological synthesis of metal nanoparticles by microbes.Adv. Colloid Interface Sci.20101561-211310.1016/j.cis.2010.02.00120181326
     [Google Scholar]
107. DasR.K. PachapurV.L. LonappanL. NaghdiM. PulicharlaR. MaitiS. CledonM. DalilaL.M.A. SarmaS.J. BrarS.K. Biological synthesis of metallic nanoparticles: Plants, animals and microbial aspects.Nanotechnol Environ Eng2017211810.1007/s41204‑017‑0029‑4
     [Google Scholar]
108. FathyA.A. ButlerI.S. Abd ElrahmanM. Jean-ClaudeB.J. MostafaS.I. Anticancer evaluation and drug delivery of new palladium(II) complexes based on the chelate of alen-dronate onto hydroxyapatite nanoparticles.Inorg. Chim. Acta2018473445010.1016/j.ica.2017.12.015
     [Google Scholar]